NCT05056844View on ClinicalTrials.gov

Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge

NARecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Breast Carcinoma
Interventions
PROCEDURE

Contrast Enhanced Digital Mammography

Undergo CESM

PROCEDURE

Digital Tomosynthesis Mammography

Undergo DBT

DRUG

Iodinated Contrast Agent

Given iodine-based contrast agent IV

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER